%0 Journal Article
%T Association Between Peripheral Blood CD19-Positive Rate and Antibody-Mediated Rejection Following Rituximab Administration in Kidney Transplant Recipients
%A Koji Nanmoku
%A Takahiro Shinzato
%A Takashi Yagisawa
%A Taro Kubo
%A Toshihiro Shimizu
%J Archive of "Transplantation Direct".
%D 2019
%R 10.1097/TXD.0000000000000907
%X Rituximab is used widely for desensitization in ABO-incompatible and donor-specific antibody-positive kidney transplantation. However, data about the effects of individual differences in rituximab-induced B-cell suppression on antibody-mediated rejection (AMR) remain unknown. We aimed to assess the association between CD19-positive rate and AMR following rituximab administration after kidney transplantation
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616141/